Trial Profile

A Phase I, Open-label, Fixed Sequence, Two-period, Crossover, Drug-drug Interaction Study to Investigate the Interaction Potential of Itraconazole on the Pharmacokinetics of Ganaplacide and Lumefantrine Combination in Healthy Participants

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ganaplacide (Primary) ; Itraconazole (Primary) ; Lumefantrine (Primary)
Indications Falciparum malaria; Malaria; Vivax malaria
Focus Pharmacokinetics
Sponsors Novartis Pharmaceuticals

12 Jun 2022 Status changed from recruiting to completed.
30 Mar 2022 Planned End Date changed from 28 Feb 2022 to 18 Apr 2022.
30 Mar 2022 Planned primary completion date changed from 28 Feb 2022 to 18 Apr 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com